/
/
/

Mankind Pharma Balance Sheet

Consolidated
Standalone
%

Share Price Live Stats

Open (₹)2,390.00
Volume (₹)98,805.00
High (₹)2,390.00
Upper Circuit2,431.00
Low (₹)2,355.40
Lower Circuit2,289.40
Prev Close2,391.50
52W High (₹)2,674.00
Price2,368.80
52W Low (₹)1,909.70

Share Market Cap & Key Ratios Overview

M.Cap (₹)98304.70 Cr
Div. Yield (%)0.04
PE Ratio48.13
Debt to Equity0.37
Price to Book5.09
Book Value393.72
EPS (TTM)49.45
Face Value1.00
ROE (%)12.69

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
LUPINNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LTP
1W Low
1W High
Market cap (₹)
1916-4 (-0.21%)
1905
1984.80
4,63,791Cr
9250+11 (0.12%)
9087
9467
2,45,081Cr
4905.5-144.5 (-2.86%)
4886.50
5066
1,90,351Cr
1143-48 (-4.03%)
1130.50
1187
1,14,833Cr
1394.7-28.8 (-2.02%)
1389.40
1426.10
1,14,163Cr
1868.5-70 (-3.61%)
1811.70
1949
1,00,660Cr
2132-39.5 (-1.82%)
2132
2192
98,431Cr
2368.8-14.1 (-0.59%)
2341.20
2419.20
98,305Cr
1155-23 (-1.95%)
1154.40
1179.90
96,906Cr
1637.3-8 (-0.49%)
1626.60
1717
95,300Cr

Key Highlights of Mankind Pharma Ltd Balance Sheet

Mankind Pharma Ltd balance sheet discloses shareholders' funds of ₹41.28Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹41.28Cr, and the reserves and surplus of the company is ₹16307.9Cr.

The company has its non-current liabilities with total liabilities of ₹24451.8Cr as of 2026-03-31.

The current liabilities are ₹5473.19Cr as of 2026-03-31. At the same time, current assets are ₹4183.13Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹15472Cr and tangible assets of ₹3925.81Cr, provided in the Mankind Pharma Ltd financial statements.